Rigel Pharmaceuticals, Inc. (RIGL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 2.73M | 21.98M | 24.03M | 30.54M | -893K | 14.5M | 21.68M | 302K | -5.01M | -6.24M | -1.36M | 5.93M |
| Operating CF Margin % | 4.63% | 31.49% | 34.6% | 30.03% | -1.67% | 25.18% | 39.2% | 0.82% | -16.97% | -17.43% | -4.83% | 22.06% |
| Operating CF Growth % | 405.15% | 51.55% | 10.85% | 10011.59% | 82.19% | 332.42% | 1695.22% | -94.91% | -23.05% | 71.52% | 89.78% | 145.93% |
| Net Income | 8.65M | 268.06M | 27.9M | 59.61M | 11.45M | 14.34M | 12.42M | -1.03M | -8.25M | 737K | -5.69M | -6.6M |
| Depreciation & Amortization | 597K | 601K | 603K | 607K | 604K | 604K | 611K | 613K | 400K | 293K | 292K | 296K |
| Stock-Based Compensation | 3.46M | 2.75M | 3.36M | 3.28M | 3.32M | 2.09M | 2.64M | 2.53M | 5.13M | 1.93M | 1.94M | 2.17M |
| Deferred Taxes | 2.57M | -245.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -12.55M | -243K | -3.91M | -40.23M | -190K | -332K | -92K | -159K | -205K | -370K | -127K | 5K |
| Working Capital Changes | 0 | -3.34M | -3.92M | 7.27M | -16.08M | -2.2M | 6.09M | -1.65M | -2.1M | -8.83M | 2.23M | 10.06M |
| Change in Receivables | 1.82M | -5.84M | -6.02M | 1.64M | 68K | -11.04M | -1.67M | -1.39M | 3.04M | -7M | -2.73M | 8.55M |
| Change in Inventory | -581K | 1.13M | 188K | -8.37M | 1.41M | 1.93M | 3.34M | -2.19M | -2.31M | 2.53M | 281K | 309K |
| Change in Payables | -2.71M | 3.35M | 0 | 3.34M | 615K | -476K | -2.31M | -3.15M | 2.13M | -857K | 2.76M | -1.05M |
| Cash from Investing | -7.97M | -25.36M | -33.17M | -23.28M | -10.55M | -10.91M | 3.8M | 10.93M | 313K | -6.87M | -1.17M | 2.97M |
| Capital Expenditures | 0 | 12K | -12K | 0 | 0 | -26K | -10K | -222K | -138K | 0 | 0 | 0 |
| CapEx % of Revenue | - | 0.02% | 0.02% | - | - | 0.05% | 0.02% | 0.6% | 0.47% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -33.16M | 0 | 0 | 72K | 26K | 0 | 0 | 110K | 22K | 0 |
| Cash from Financing | -10.92M | -4.57M | 4.27M | 418K | 484K | 1.47M | -9.84M | -752K | -2.51M | 486K | -869K | -373K |
| Debt Issued (Net) | 0 | -7.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 2.93M | 0 | 418K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -3.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -10.92M | 0 | 4.27M | 0 | 484K | 1.47M | -9.84M | -752K | -2.51M | 486K | -869K | -373K |
| Net Change in Cash | -16.17M | -7.95M | -4.87M | 7.68M | -10.96M | 5.05M | 15.64M | 10.48M | -7.21M | -12.63M | -3.4M | 8.53M |
| Free Cash Flow | 2.73M | 21.99M | 24.02M | 30.54M | -893K | 14.48M | 21.67M | 80K | -5.15M | -6.24M | -1.36M | 5.93M |
| FCF Margin % | 4.63% | 31.51% | 34.58% | 30.03% | -1.67% | 25.14% | 39.18% | 0.22% | -17.44% | -17.43% | -4.83% | 22.06% |
| FCF Growth % | 405.15% | 51.91% | 10.85% | 38071.25% | 82.66% | 332% | 1694.48% | -98.65% | 72.99% | 71.61% | 89.93% | 146.06% |
| FCF per Share | 0.14 | 1.17 | 1.25 | 1.68 | -0.05 | 0.80 | 1.23 | 0.00 | -0.29 | -0.36 | -0.08 | 0.34 |
| FCF Conversion (FCF/Net Income) | 0.31x | 0.08x | 0.86x | 0.51x | -0.08x | 1.01x | 1.75x | -0.29x | 0.61x | -8.47x | 0.24x | -0.90x |
| Interest Paid | 0 | 0 | 1.68M | 0 | 1.65M | 1.75M | 1.83M | 1.77M | 1.68M | 1.68M | 1.68M | 1.47M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |